We are the DNA methylation team!
HKG Epitherepaeutics Ltd and its subsidiary in Canada, MTL Epitherapeutics were founded by Prof. Moshe Szyf, a leading world pioneer in the exciting and rapidly emerging science of Epigenetics.
A Canadian company, dedicated to harnessing the untapped power and possibilities of Epigenetics (Research and development lab is located at the HKG Science and Technology Park in Shatin, in Hong Kong).
Simply stated, the science of Epigenetics centers on DNA Methylation (a simple biochemical process) that changes a mark on your DNA when cancer or other catastrophic diseases may develop.
While the company is new, Szyf’s three decades of ground-breaking research and cutting-edge innovations in Epigenetics — how it occurs and how it is passed from generation to generation — has already disrupted medical science with its potential to detect, diagnose, prevent or cure diseases.
Our targeted Bisulfite Sequencing uses Illumina MiSeq next generation bisulfite sequencing. Our service includes: Bisulfite treatment, primer design for targeted regions, PCR1 amplification to enrich target, PCR2 amplification to add barcode, NGS library prep, Illumina-based NGS sequencing and Bioinformatics analysis. Approximate turnaround time 4-8 weeks.
DNA methylation analysis of psychiatry and behavioral related genes
Our targeted Bisulfite Sequencing uses Illumina MiSeq to assess the DNA methylation level of the behavioral related genes: FKBP5, NR3C1, BDNF, IL6 and OXTR.
MTL Epitherapeutics Inc. has not received any reviews.
MTL Epitherapeutics Inc. has not received any endorsements.